AZ, J&J, Otsuka Stand Out For Work On Little-Profit TB Treatments
This article was originally published in PharmAsia News
As the World Health Organization releases new reports about the difficulty of fighting tuberculosis, particularly in the undeveloped world, the global pharmaceutical industry has not shown much interest in the disease.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.